ABSTRACT

There is an emerging role of artificial intelligence (AI) in endoscopy with studies on early systems showing promising results. However, various limitations inhibit widespread use. The aim of this study was to ascertain the sentiments of endoscopists and understand the benefits and barriers towards adoption of AI systems into healthcare. An anonymous online 18-question survey was disseminated to gastroenterology and surgical departments across UK. A total of 75 endoscopists completed the questionnaire. The majority felt that AI would increase adenoma detection rate (ADR) (72.8%) and aid lesion characterisation (78.6%). However, only a quarter of respondents were either moderately or very familiar with AI, and there was no consensus on necessity of AI in endoscopy. The key barriers identified were cost, accessibility and lack of guidelines. Endoscopists believe AI systems will have a positive impact on endoscopy; however, these systems must provide quality assurance through large clinical trials before adoption.

摘要

人工智能 (AI) 在内窥镜检查中发挥着新兴作用，对早期系统的研究显示出有希望的结果。然而，各种限制阻碍了广泛使用。本研究的目的是确定内窥镜医师的情绪，并了解将人工智能系统应用于医疗保健的好处和障碍。一项包含 18 个问题的匿名在线调查已分发给英国各地的胃肠病学和外科部门。共有 75 名内镜医师完成了问卷调查。大多数人认为 AI 会提高腺瘤检出率 (ADR) (72.8%) 并有助于病变表征 (78.6%)。然而，只有四分之一的受访者对人工智能有一定的了解或非常熟悉，并且对于人工智能在内窥镜检查中的必要性还没有达成共识。确定的主要障碍是成本、可及性和缺乏指南。内窥镜专家认为人工智能系统将对内窥镜检查产生积极影响；然而，这些系统必须在采用前通过大型临床试验提供质量保证。